EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE
2013 ◽
Vol 12
(4)
◽
pp. 75-78
Keyword(s):
Expert Consensus. Role of combination lipid-lowering therapy (simvastatin/ezetimibe 20/10 mg) in the correction of lipid metabolism disturbances in patients with chronic kidney disease.
Keyword(s):
2012 ◽
Vol 47
(1)
◽
pp. 117-123
◽
Keyword(s):
2012 ◽
Vol 157
(4)
◽
pp. 251
◽
Keyword(s):
2004 ◽
Vol 44
(5)
◽
pp. 917-920
◽
Keyword(s):
Is Non Dipping Hypertension Associated with Dyslipidemia, Type 2 Diabetes or Chronic Kidney Disease?
2013 ◽
Vol 20
(3)
◽
pp. 331-337
2012 ◽
Vol 38
(3)
◽
pp. 138-146
◽
Keyword(s):
2008 ◽
Vol 47
(17)
◽
pp. 1505-1510
◽
Keyword(s):